V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190010127 | 190005069 | 1.73 | null | null | 2019-11-11 | 2020-01-23 | POMB/ACE | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100767437 |
| 190010128 | 190005070 | 1.57 | 89.7 | null | 2015-09-23 | 2016-07-16 | OST Euramos 1 Closed Trial - AP | N | N | CISPLATIN + DOXORUBICIN + METHOTREXATE + MIFAMURTIDE | 101335572 |
| 190010131 | 190005071 | 1.85 | 23.6 | Palliative (P) | 2018-09-15 | 2018-09-30 | EVEROLIMUS | 02 | Y | CARBOPLATIN + DOXORUBICIN | 101245049 |
| 190010132 | 190005072 | 1.64 | 93.55 | null | 2021-09-18 | 2021-09-21 | EW EuroEwing 2012 Arm B VDC | 01 | N | CT7001 TRIAL | 100614616 |
| 190010133 | 190005073 | 1.72 | 88.3 | Adjuvant (A) | 2019-02-17 | 2019-02-17 | EW EuroEwing 2012 Arm B VDC | 02 | N | TRABECTEDIN | 100458479 |
| 190010137 | 190005074 | 0 | 69.3 | Curative (C) | 2018-03-18 | 2018-04-14 | DOXORUBICIN | N | Y | DOXORUBICIN | 100807503 |
| 190010142 | 190005075 | 1.64 | 68.1 | Curative (C) | 2018-08-31 | 2018-10-17 | EW EuroEwing 99 : VActI | 02 | N | MAP | 100050103 |
| 190010145 | 190005076 | 1.57 | 63.5 | null | 2017-02-18 | 2017-03-04 | NIVOLUMAB | 02 | N | NOT MATCHED | 100657824 |
| 190010146 | 190005077 | 0 | 66.8 | null | 2017-12-28 | 2017-12-29 | DOXORUBICIN | 02 | null | DOXORUBICIN | 100523946 |
| 190010149 | 190005078 | 1.77 | 96 | Neo-adjuvant (N) | null | 2016-11-06 | Doxorubicin 75mg/m2 | 01 | N | DOXORUBICIN | 101374283 |
| 190010150 | 190005079 | 1.72 | 88 | Curative (C) | 2018-07-01 | 2018-07-16 | DACTINOMYCIN + CYCLO + VINCRISTINE | null | null | CARBOPLATIN + ETOPOSIDE | 100080628 |
| 190010151 | 190005080 | 1.63 | 86.6 | Palliative (P) | null | 2019-09-11 | Oxaliplatin + Modified de Gramont | 02 | N | OST MIFAMURTIDE | 101185899 |
| 190010165 | 190005081 | 1.84 | 96.1 | Curative (C) | null | 2018-09-09 | DOXORUBICIN | 02 | null | DOXORUBICIN | 100861594 |
| 190010169 | 190005082 | 0 | 14.3 | null | null | 2017-06-27 | PAM x 2 post-surgery (cycles 3&4) | null | null | CAV | 100703440 |
| 190010174 | 190005083 | 1.6 | 41.5 | Neo-adjuvant (N) | 2019-05-24 | 2019-11-18 | EW EuroEwing 2012 Arm B VC | 02 | N | EW EUROEWING 2012 ARM B VC | 100302019 |
| 190010178 | 190005084 | 1.72 | 75 | null | 2019-07-08 | 2019-07-08 | EW EuroEwing 2012 Arm A VAC | 2 | null | TRIAL | 101243503 |
| 190010184 | 190005085 | 1.6 | 64 | Palliative (P) | 2019-02-01 | 2019-03-13 | Etoposide + Ifosfamide (5 days) | 02 | null | ETOPOSIDE + IFOSFAMIDE | 101784800 |
| 190010186 | 190005086 | 1.76 | 100.5 | Curative (C) | null | 2019-03-12 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100629783 |
| 190010190 | 190005087 | 1.63 | 74 | Palliative (P) | 2015-11-16 | 2016-07-25 | Paclitaxel 7 day | 02 | N | CARBOPLATIN + GEMCITABINE | 100306730 |
| 190010197 | 190005088 | null | 76 | Curative (C) | null | 2018-07-05 | ETOPOSIDE + IFOSFAMIDE | null | null | ETOPOSIDE + IFOSFAMIDE | 101144071 |
| 190010203 | 190005089 | 0 | 68.7 | Palliative (P) | 2019-12-24 | 2019-12-24 | PACLITAXEL | 02 | N | TRIAL | 100229830 |
| 190010207 | 190005090 | 1.66 | 28.6 | Curative (C) | 2017-10-17 | 2017-10-28 | EW EuroEwing 2012 Arm A VAC | 02 | N | CISPLATIN + DOXORUBICIN | 101468612 |
| 190010208 | 190005091 | 1.5 | 43.5 | Neo-adjuvant (N) | 2018-05-28 | 2018-06-18 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 100558816 |
| 190010209 | 190005092 | 1.73 | 65.05 | null | 2019-05-26 | 2019-06-16 | OST Euramos 1 Closed Trial - M | 02 | N | OST M | 101521478 |
| 190010210 | 190005093 | 1.63 | 56 | Palliative (P) | 2018-06-17 | 2018-07-02 | CARBOPLATIN + ETOPOSIDE | 02 | null | DOXORUBICIN + METHOTREXATE | 101445112 |
| 190010212 | 190005094 | 1.81 | 63.2 | Neo-adjuvant (N) | 2018-06-20 | 2018-06-20 | OST Euramos 1 Closed Trial - A | 02 | N | OST A | 100469691 |
| 190010215 | 190005095 | 1.83 | 75.8 | Palliative (P) | 2019-11-26 | 2019-12-17 | NB BEACON Temozolomide Irinotecan | 02 | N | EW EUROEWING 2012 ARM A VAI | 100957220 |
| 190010216 | 190005096 | null | 94.3 | Curative (C) | 2018-08-29 | 2018-09-14 | Methotrexate Intermed dose (1g/m2) | 02 | Y | METHOTREXATE | 101755258 |
| 190010230 | 190005097 | 1.87 | 63.4 | Curative (C) | null | 2019-07-25 | EW EuroEwing 2012 Arm B IE | 02 | null | EW EUROEWING 2012 ARM B IE | 101443810 |
| 190010231 | 190005098 | 0 | 29 | null | null | 2020-04-04 | OST Mifamurtide | 02 | N | IRINOTECAN + TEMOZOLOMIDE | 100343325 |
| 190010232 | 190005099 | 1.89 | 59 | Palliative (P) | 2020-10-18 | 2020-10-25 | OST Euramos 1 Closed Trial - M | 02 | null | OST M | 100717091 |
| 190010237 | 190005100 | 1.69 | 90.05 | null | 2019-10-31 | 2019-10-31 | Ifosfamide | 02 | N | OST IE | 100204635 |
| 190010239 | 190005101 | 1.72 | 10.4 | null | 2017-08-03 | 2017-08-03 | OST Euramos 1 Closed Trial - A | N | N | OST A | 100041525 |
| 190010245 | 190005102 | 1.7 | 94.3 | Adjuvant (A) | 2018-07-12 | 2018-07-12 | EW EuroEwing 2012 Arm B IE | N | N | EW EUROEWING 2012 ARM B IE | 101194627 |
| 190010254 | 190005103 | 1.83 | 35.1 | Neo-adjuvant (N) | 2016-10-28 | 2016-11-12 | EW EuroEwing 2012 Arm A VAC | 02 | null | EURAMOS TRIAL | 101655316 |
| 190010258 | 190005104 | null | 83 | Neo-adjuvant (N) | 2016-04-09 | 2016-09-29 | NB HRNBL-1 Isotretinoin | 02 | Y | IMATINIB | 100204570 |
| 190010259 | 190005105 | 1.71 | 64.6 | null | 2018-03-31 | 2018-09-18 | null | 02 | null | EW EUROEWING 2012 ARM B VDC/IE | 101864734 |
| 190010272 | 190005106 | null | 99.2 | Curative (C) | 2017-06-20 | 2017-06-20 | GEMCITABINE + TIP | 02 | N | NOT MATCHED | 101575286 |
| 190010285 | 190005107 | 1.66 | 82.1 | Neo-adjuvant (N) | 2016-04-24 | 2016-04-25 | null | 02 | null | VIDE | 100136710 |
| 190010287 | 190005108 | 1.57 | 85.5 | Curative (C) | null | 2018-10-06 | FLUOROURACIL + OXALIPLATIN | 02 | N | DOXORUBICIN + HD MTX | 100344296 |
| 190010289 | 190005109 | 1.57 | 115.5 | Palliative (P) | null | 2019-04-08 | CARBOPLATIN + RT | 02 | N | IFOSFAMIDE | 100576507 |
| 190010293 | 190005110 | 0 | 25.3 | Curative (C) | 2018-07-19 | 2018-09-06 | ETOPOSIDE + IFOSFAMIDE | 02 | N | ETOPOSIDE + IFOSFAMIDE | 101826975 |
| 190010295 | 190005111 | 1.5 | 41.9 | null | 2018-11-24 | 2018-11-29 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101658414 |
| 190010298 | 190005112 | 0 | 68.7 | Palliative (P) | null | 2017-12-08 | METHOTREXATE | null | null | METHOTREXATE | 101616146 |
| 190010303 | 190005113 | 1.75 | 62.5 | Neo-adjuvant (N) | 2016-02-27 | 2016-03-19 | EW EuroEwing 2012 Arm B VC | 02 | null | EW EUROEWING 2012 ARM B VC | 100662844 |
| 190010305 | 190005114 | 1.66 | 48.4 | Neo-adjuvant (N) | 2015-11-04 | 2016-06-16 | PEMBROLIZUMAB | 99 | N | IFOSFAMIDE | 100015398 |
| 190010308 | 190005115 | 1.57 | 38.7 | null | 2018-01-18 | 2018-01-29 | Capecitabine + Oxaliplatin 21day | 02 | null | CYCLOPHOSPHAMIDE + ETOPOSIDE | 100028419 |
| 190010329 | 190005116 | 1.61 | 73 | Curative (C) | 2017-07-21 | 2017-08-03 | EW EuroEwing 2012 Arm A VAI | 01 | N | ETOPOSIDE | 100820212 |
| 190010345 | 190005117 | 1.78 | 89.8 | Palliative (P) | null | 2019-05-18 | FLUOROURACIL + IRINOTECAN | 02 | N | STS NON-RHABDO EPSSG 2005 VDCY | 100095564 |
| 190010347 | 190005118 | 1.65 | 98.7 | Palliative (P) | 2017-01-15 | 2017-01-15 | EW EuroEwing 2012 Arm B IE | 02 | N | EW EUROEWING 2012 ARM B IE | 100457965 |